Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Fibrosis Syndrome 2Pancreatic Neoplasms 2Pancreatic Adenocarcinoma 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Ductal Adenocarcinoma 1Osteosarcoma 1Neuroma, Acoustic 1Inflammation 1Fibrosis 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Camurati-Engelmann Syndrome 1

Interventions

epigallocatechin gallate 2Ascorbic Acid 2semaglutide 1salicylsalicylic acid 1microcrystalline cellulose 1dapagliflozin 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1XENP 1595 1Vitamin D 1Topiramate 1Tirzepatide 1Tablets 1Spirometry 1Specimen Handling 1Sodium Salicylate 1Selenium 1Saline Solution 1Resistance Training 1Reperfusion 1Qsymia 1Probiotics 1Pregabalin 1Platelet Count 1Plastic Surgery Procedures 1Phentermine 1Omeprazole 1Naltrexone 1Losartan 1Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Losartan × 1 year × Clear all
NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Shaw Cancer Center

Phase 2 Recruiting
43 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡